3648 results for «589»

Filter By

3648 results

TAVI and aortic valve procedures

11 Oct 2025 – From AICT-AsiaPCR 2025

Focusing on transcatheter aortic valve interventions, this session covers a broad spectrum of complex cases including emergent TAV-in-SAV procedures, management of severely calcified bicuspid valves, zero-contrast TAVI techniques, and strategies for hostile anatomies. It provides valuable insights into procedural planning and follow-up to optimize patient care...

Valve-in-valve in degenerated surgical bioprothesis mitral valve - LIVE Case

10 Oct 2025 – From AICT-AsiaPCR 2025

A 78-year-old male with a history of rheumatic disease underwent surgical mitral valve replacement (Perimount Magna 25), surgical aortic valve replacement (Perimount Magna), and CABG (LIMA–LAD) in 2010. He presented with symptomatic severe mitral regurgitation and normal LV function.

He was treated with implantation of a 26...

Valve-in-valve in degenerated surgical bioprothesis mitral valve - LIVE Case

IVUS or OCT? Choosing the right imaging for the right lesion - A case-based debate

10 Oct 2025 – From AICT-AsiaPCR 2025

This case-based debate examines the complementary roles of IVUS and OCT imaging modalities in precision PCI. It highlights lesion-specific factors guiding modality choice, including left main disease, bifurcations, calcified plaques, and acute coronary syndromes, supported by real-world clinical cases demonstrating imaging-based decision-making.

EuroPCR 2018 Opening Ceremony and Ethica Awards

22 May 2018 – From EuroPCR 2018

Join J. Fajadet and W. Wijns for the EuroPCR 2018 Opening Ceremony and find out who this year's Ethica Awards winners are!

EuroPCR 2018 Opening Ceremony and Ethica Awards

RESHAPE-HF2 - Percutaneous repair of moderate-to-severe or severe functional mitral regurgitation in patients with symptomatic heart failure

01 Sep 2024

Nicola Ryan provides her take on the RESHAPE-HF2 trial presented by Stefan Anker at the ESC Congress 2024 in London and simultaneously published in the NEJM.

The RESHAPE-HF 2 trial is a prospective randomised control trial comparing transcatheter mitral valve repair (TEER) and guideline-directed medical therapy to guideline-directed medical...

Nicola Ryan

Author

Nicola Ryan
RESHAPE-HF2

Aortic stenosis and coronary artery disease: which should be treated first?

18 Jun 2026

In this review, Henryk Dreger explores the complex interplay between aortic stenosis and coronary artery disease, highlighting the latest evidence on PCI timing and its implications for clinical decision-making.

Henryk Dreger

Author

Henryk Dreger
Aortic stenosis and coronary artery disease: which should be treated first?

RENOVATE-COMPLEX-PCI: Intravascular imaging-guided versus angiography-guided procedural optimization in complex percutaneous coronary intervention

06 Mar 2023

Daniele Giacoppo reports the main results of the RENOVATE-COMPLEX-PCI trial presented by Joo-Yong Hahn, from the Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea, in a Late-Breaking Trial session at the American College of Cardiology (ACC) 2023 / World...

Daniele Giacoppo

Author

Daniele Giacoppo
RENOVATE-COMPLEX-PCI: Intravascular imaging-guided versus angiography-guided procedural optimization in complex percutaneous coronary intervention

Comparison of a precision care strategy with usual testing to guide management of stable patients with suspected CAD: the PRECISE randomized trial

09 Nov 2022

Alex Sticchi provides his take on PRECISE, which was presented during AHA 2022 in Chicago.

Alessandro Sticchi

Author

Alessandro Sticchi
Comparison of a precision care strategy with usual testing to guide management of stable patients with suspected coronary artery disease: the PRECISE randomized trial
Didn’t find what you were looking for?